Phase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumors.
Mross K, Stefanic M, Gmehling D, Frost A, Baas F, Unger C, Strecker R, Henning J, Gaschler-Markefski B, Stopfer P, de Rossi L, Kaiser R.
Mross K, et al. Among authors: de rossi l.
Clin Cancer Res. 2010 Jan 1;16(1):311-9. doi: 10.1158/1078-0432.CCR-09-0694. Epub 2009 Dec 22.
Clin Cancer Res. 2010.
PMID: 20028771
Clinical Trial.